The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients.
Saved in:
| Title: | The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients. |
|---|---|
| Authors: | Charbonnel, Bernard1 bernard.charbonnel@sante.univ-nantes.fr, Dormandy, John2, Erdmann, Erland3, Masssi-Benedetti, Massimo4, Skene, Allan5, Massi-Benedetti, Massimo (AUTHOR), PROactive Study Group (CORPORATE AUTHOR) |
| Source: | Diabetes Care. Jul2004, Vol. 27 Issue 7, p1647-1653. 7p. 3 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 01495992 |
|---|---|
| DOI: | 10.2337/diacare.27.7.1647 |
